# Critical Evaluation of Coordination Hypotheses
## Hypothesis 1: MFN2-PACS2 MAM Axis
### Weak Links
- **MFN2's role as a direct mitophagy receptor is contested**: While PMID:31171695 demonstrates MFN2-LC3 interaction, most literature treats MFN2 primarily as a fusion regulator. Its LIR motif functionality varies by context and species.
- **PACS2 connection to mitophagy is inferential**: PACS2 regulates ER-mitochondria tethering, but evidence for direct involvement in mitophagy initiation is circumstantial.
- **Causality vs. correlation of MAM disruption**: PMID:31641032 shows MAM integrity is compromised in ALS/PD, but doesn't establish this drives coordination failure rather than reflecting a downstream effect.
### Counter-Evidence
- MFN2 knockdown could impair mitophagy indirectly via fusion defects rather than receptor function—fused mitochondria are harder to segregate for autophagic clearance.
- PACS2 is primarily studied in ER quality control; its role in coordinating dual pathways remains speculative.
### Falsifying Experiment
- Perform rescue experiments with MFN2 constructs lacking LIR motif but maintaining fusion function. If mitophagy-ER-phagy coordination still fails, the axis requires the receptor function; if coordination is maintained, the axis is downstream of mitochondrial dynamics.
### Revised Confidence: **0.58** (down from 0.72)
---
## Hypothesis 2: TFEB/TFE3 Parallel Activation
### Weak Links
- **Non-specific survival effect**: TFEB/TFE3 double KO neurodegeneration (PMID:31801954) could reflect general lysosomal failure, not specifically the loss of "coordination."
- **Promoter binding divergence is unproven**: The assertion that TFEB/TFE3 preferentially drive mitophagy vs. ER-phagy genes lacks direct ChIP-seq evidence in neurons.
- **Heterodimerization evidence is indirect**: TFE3 compensating for TFEB loss suggests redundancy, not active coordination.
### Counter-Evidence
- TFEB/TFE3 activation is triggered by general stress (mTORC1 inhibition, AMPK). This would induce coordinated response only if the stress simultaneously affects multiple organelles—which may not be the case in disease-specific contexts.
- The CLEAR network (PMID:26942069) includes general autophagy genes; organelle-specific targeting requires additional cargo receptor specificity beyond TFEB/TFE3.
### Falsifying Experiment
- Use dCas9-KRAB to selectively repress TFEB or TFE3 binding at organelle-specific gene promoters (determined by neuron-specific ChIP-seq). If only one pathway is impaired, divergence exists; if both fail, coordination is downstream of both factors.
### Revised Confidence: **0.64** (down from 0.78)
---
## Hypothesis 3: TBK1-OPTN-NDP52 Phospho-Cascade
### Weak Links
- **Receptor specificity for ER is underexplored**: OPTN for ER-phagy (PMID:32048902) is documented under starvation, but whether TBK1-phosphorylated OPTN engages ER membranes under disease conditions is unclear.
- **NDP52 ER targeting is controversial**: The cited Salmonella literature (PMID:25985789) involves cytosolic bacteria, not organelle-specific ER fragments. Direct NDP52 engagement of ER vesicles lacks validation.
- **"Broadcast" model lacks kinetic evidence**: No data showing TBK1 activation precedes coordinated multi-organelle recruitment in real-time.
### Counter-Evidence
- TBK1 mutations cause ALS primarily through motor neuron-specific vulnerability; if TBK1 coordinated all organelle quality control, you'd expect broader tissue effects.
- Loss-of-function mutations should impair all selective autophagy equally if the model is correct—but some TBK1 mutations show tissue-specific phenotypes.
### Falsifying Experiment
- Perform live-cell imaging of TBK1 activation (using FRET sensor) simultaneously with OPTN and NDP52 recruitment to mitochondria vs. ER. If TBK1 activation precedes both recruitments with similar kinetics, the model holds; if organelle-specific recruitment is sequential or TBK1-independent, the hub model fails.
### Revised Confidence: **0.68** (down from 0.81)
---
## Hypothesis 4: p62 Phase Separation
### Weak Links
- **Mixed-organelle capture is not demonstrated**: PMID:31506447 shows p62 bodies "capture both mitochondria and ER," but doesn't prove a single droplet contains both organelles simultaneously—it could be adjacent separate droplets.
- **LLPS specificity for damaged organelles**: p62 LLPS is triggered by ubiquitylated cargo; damaged mitochondria and ER may have different ubiquitin chain types that partition into distinct droplets.
- **Phase separation does not equal coordinated clearance**: Concentrating cargo doesn't guarantee both are delivered to the same autophagosome.
### Counter-Evidence
- Some studies suggest p62 bodies are organelle-specific, forming distinct mitochondrial vs. ER-associated puncta.
- p62's primary function may be aggregate clearance rather than dynamic organelle quality control.
### Falsifying Experiment
- Use super-resolution STORM with 3D rendering to definitively show whether individual p62 droplets contain both Tom20+ and Sec61+ signals in the same aqueous compartment. Perform FRAP to confirm liquid-phase mixing. If organelles remain segregated within distinct p62 droplets, the coordination model fails.
### Revised Confidence: **0.61** (down from 0.75)
---
## Hypothesis 5: VPS34 Complex I Heterogeneity
### Weak Links
- **PI3P signaling is generic**: PI3P at ER initiates autophagy but doesn't determine organelle specificity—cargo receptors do.
- **NRBF2 recruitment to MAMs (PMID:27840058)**: Demonstrates localization but doesn't prove NRBF2 discriminates between mitophagy vs. ER-phagy substrates.
- **Complex composition may be constitutive**: VPS34 complexes may set basal autophagic capacity, not dynamic organelle-specific targeting.
### Counter-Evidence
- VPS34 inhibitors (SAR405) block general autophagy; no selective effect on one pathway over another has been demonstrated.
- UVRAG mutations causing neurodegeneration (PMID:25985789) affect overall autophagic flux, not specific organelle clearance.
### Falsifying Experiment
- Use rapid immunoprecipitation of endogenous VPS34 complexes followed by mass spec under different stresses. If complex subunits don't significantly rewire within 30 minutes of stress, specificity is set by other mechanisms; if complexes change composition dynamically, test whether swapping subunits redirects PI3P to the alternative organelle.
### Revised Confidence: **0.52** (down from 0.65)
---
## Hypothesis 6: Calcium Microdomain Crosstalk
### Weak Links
- **Temporal sequence is unclear**: Does calcium flux first trigger mitophagy, then ER-phagy, or simultaneously? The mechanism for parallel initiation is vague.
- **IRE1α/PERK activation doesn't exclusively drive ER-phagy**: These sensors trigger integrated stress response including apoptosis; attributing ER-phagy specifically to their activation is reductive.
- **VDAC1 oligomerization (PMID:29162697)**: While demonstrated, VDAC1 is on the OMM and doesn't directly interface with ER-phagy machinery.
### Counter-Evidence
- Calcium-induced mitophagy (PMID:25895059) involves mitochondrial permeability transition pore opening—a lethal signal. Whether this represents coordinated quality control vs. pathology is debated.
- IP3R1 dysfunction in HD (PMID:28666991) causes metabolic deficits; the "ER-phagy" consequence is inferred, not measured.
### Falsifying Experiment
- Use targeted optogenetics to uncouple mitochondrial calcium uptake from ER calcium release temporally. If ER-phagy can be triggered by IP3R1 activation without mitochondrial calcium uptake (and vice versa), the coupling model fails. Measure each pathway independently with high temporal resolution.
### Revised Confidence: **0.58** (down from 0.70)
---
## Hypothesis 7: NAD+/SARM1 Axis
### Weak Links
- **SARM1 is injury-activated, not disease-relevant**: SARM1's primary role is acute axonal degeneration after injury (PMID:30209461). Whether this mechanism applies to chronic neurodegeneration is unclear.
- **NAD+ depletion is a general stress signal**: Low NAD+ triggers many pathways; attributing specific coordination to SARM1 vs. PARP1 or other NAD+-consuming enzymes is difficult.
- **SIRT3 (mitochondrial) vs. general ER NAD+ sensing**: SIRT3 is mitochondrial; ER NAD+ sensing mechanisms are less characterized.
### Counter-Evidence
- NMN supplementation (PMID:30341063) improves organelle quality, but this may reflect general bioenergetic support, not specific coordination.
- SARM1 knockout is neuroprotective in injury models but doesn't prevent all neurodegenerative pathology.
### Falsifying Experiment
- Measure organelle-specific autophagy flux in SARM1 KO vs. PARP1 KO vs. dual KO neurons. If SARM1 deletion specifically impairs both pathways while PARP1 deletion only affects one, the model holds. If NAD+ restoration bypasses SARM1 requirement, SARM1 is upstream but not specific to coordination.
### Revised Confidence: **0.49** (down from 0.62)
---
## Revised Summary
| # | Target | Original | Revised | Major Issue |
|---|--------|----------|---------|-------------|
| 1 | MFN2/PACS2 | 0.72 | **0.58** | Direct coordination mechanism unsupported |
| 2 | TFEB/TFE3 | 0.78 | **0.64** | General lysosomal effect, not specific coordination |
| 3 | TBK1-OPTN-NDP52 | 0.81 | **0.68** | ER-targeting of receptors insufficiently validated |
| 4 | p62 LLPS | 0.75 | **0.61** | Organelle co-localization in droplets unproven |
| 5 | VPS34 complexes | 0.65 | **0.52** | PI3P specificity insufficient for coordination |
| 6 | Calcium signaling | 0.70 | **0.58** | Temporal coupling to parallel pathways weak |
| 7 | NAD+/SARM1 | 0.62 | **0.49** | Injury-specific mechanism doesn't fit chronic disease |
---
## Overarching Methodological Concerns
1. **Multi-reporter assays are technically challenging**: Simultaneous measurement of mitophagy and reticulophagy in neurons requires non-overlapping fluorophores with different photostability, complicating long-term imaging.
2. **Causality vs. correlation in disease models**: Most cited PMIDs use models (iPSC neurons, patient tissue) showing associations. Direct intervention data (rescue experiments) are sparse.
3. **Temporal resolution missing**: None of the hypotheses address *when* coordination occurs—during initiation, elongation, or lysosomal degradation. Coordination at different stages may have different mechanisms.
4. **Cell type specificity**: Most evidence is from non-neuronal cells or cell lines. Neurons have unique bioenergetics and organelle distribution (axonal mitochondria, synaptic ER) that may alter coordination mechanisms.
---
## Recommended Priority Experiments
1. **Single-cell correlated light-electron microscopy** to definitively show multiple organelles within single autophagic structures
2. **Temporal knockdown experiments** distinguishing initiation vs. progression coordination
3. **Human genetics beyond ALS**: Test whether variants in these genes modify risk for non-ALS neurodegenerative diseases (AD, PD without ALS)